(J Am Heart Assoc. 2020;9:e014534 DOI: 10.1161/JAHA.119.014534.)32172655

For Sources of Funding and Disclosures, see page 11.

Clinical PerspectiveWhat Is New?To our best knowledge, this is the first study to analyze the interaction between sex, age, and hospital caseload in abdominal aortic aneurysm surgery.Increasing annual hospital caseload seems to lower the risk for in‐hospital mortality in male patients of all age groups.The effect in female patients is more complex, and hospital volume does not have a consistent effect on outcome.What Are the Clinical Implications?In‐hospital mortality is likely to be reduced in male patients, if they are treated in high‐volume hospitals.In women, who innately bear a higher risk of in‐hospital death, the anticipated effect of centralization on mortality seems not to be as strong as in men.

 {#jah34917-sec-0008}

Nonstandard Abbreviations and Acronyms**AAA** abdominal aortic aneurysm**DRG** diagnosis related groups**EVAR** endovascular aortic repair**iAAA** intact AAA**ICD‐10‐GM** international classification of diseases, tenth revision, German modification**OAR** open aortic repair**OR** odds ratio**rAAA** ruptured AAA

 {#jah34917-sec-0009}

Similar to the situation with other cardiovascular diseases, women are reported to have unfavorable outcomes after treatment of abdominal aortic aneurysms (AAAs) by endovascular repair (EVAR) or open aortic repair (OAR).[1](#jah34917-bib-0001){ref-type="ref"} Treatment strategies for women therefore require optimization.

When analyzing men and women together, associations between annual hospital volume and outcome, particularly death, after elective AAA surgery have been described across several countries and healthcare systems.[2](#jah34917-bib-0002){ref-type="ref"}, [3](#jah34917-bib-0003){ref-type="ref"}, [4](#jah34917-bib-0004){ref-type="ref"}, [5](#jah34917-bib-0005){ref-type="ref"}, [6](#jah34917-bib-0006){ref-type="ref"}, [7](#jah34917-bib-0007){ref-type="ref"} This led to inclusion of minimal threshold recommendations in the treatment guidelines from the Society of Vascular Surgery[8](#jah34917-bib-0008){ref-type="ref"} and the European Society of Vascular and Endovascular Surgery.[9](#jah34917-bib-0009){ref-type="ref"} The ideal threshold is still elusive, and varies depending on study design and healthcare system. In addition, it remains unclear whether only high‐risk subgroups of patients are affected by worse outcomes in low‐volume hospitals, as has been shown for percutaneous cardiac interventions.[10](#jah34917-bib-0010){ref-type="ref"} Objectification and clarification are necessary, as centralization of AAA care is increasingly discussed for improvement of outcomes.

In a recent analysis of nationwide German data on outcomes after AAA surgery, it was shown that the lowest risk for in‐hospital death was achieved in centers treating \>75 cases per year (OAR and EVAR combined).[11](#jah34917-bib-0011){ref-type="ref"} A second analysis revealed female sex and increasing age to be important risk factors for mortality.[12](#jah34917-bib-0012){ref-type="ref"} To date, the volume‐outcome relationship has not been investigated separately for women and men or young and elderly patients. Therefore, the objective of the present study was to analyze whether sex and age are effect modifiers or confounders of the association between hospital volume and mortality.

Methods {#jah34917-sec-0010}
=======

Data Source {#jah34917-sec-0011}
-----------

A retrospective data analysis was performed using the 2005 to 2014 hospital episode microdata that are statutorily gathered by the German Federal Statistical Office.[13](#jah34917-bib-0013){ref-type="ref"} As reporting of inpatient cases is regulated by law (§21 Hospital Remuneration Act), this database enables a complete nationwide survey (except military and psychiatry services). Using controlled remote data processing, it can be used for secondary data analyses for scientific purposes. Individual patient data or institutional identifiers for hospitals were not available to the authors. The method of controlled remote data processing was established and published in earlier studies.[11](#jah34917-bib-0011){ref-type="ref"}, [12](#jah34917-bib-0012){ref-type="ref"}, [14](#jah34917-bib-0014){ref-type="ref"}, [15](#jah34917-bib-0015){ref-type="ref"}, [16](#jah34917-bib-0016){ref-type="ref"}, [17](#jah34917-bib-0017){ref-type="ref"}

Because of the sensitive nature of the data collected for this study, application to the German Federal Statistical Office is necessary for primary data access. Qualified researchers trained in human subject confidentiality protocols may apply at <https://www.forschungsdatenzentrum.de/de/bedingungen> and use data for secondary data analyses according to defined conditions.

The authors followed the guideline for Good Practice of Secondary Data Analysis[18](#jah34917-bib-0018){ref-type="ref"} as well as the STROSA2 (Standardisierte BerichtsRoutine für Sekundärdaten Analysen \[Standardised Reporting Routine for Secondary Data Analysis\]) guideline,[19](#jah34917-bib-0019){ref-type="ref"} which is a modification of RECORD (Reporting of studies Conducted using Observational Routinely‐collected Data)[20](#jah34917-bib-0020){ref-type="ref"} focusing on the peculiarities of the German healthcare system. The local ethics committee of the Medical Faculty, Technical University of Munich, approved the study (reference 21/16 S). Informed consent was not required.

Case Selection and Population {#jah34917-sec-0012}
-----------------------------

As in‐hospital episodes are recorded without an individual patient identifier, this study describes cases rather than individual patients. Between January 1, 2005, and December 31, 2014, all cases with a principal or secondary diagnosis of intact AAA (iAAA; *International Classification of Diseases, Tenth Revision, German Modification* \[*ICD‐10‐GM*\] I71.4; includes all AAA without signs of rupture) and specific treatment (defined as specific procedure codes, "operationen‐ und prozedurenschlüssel", for infrarenal EVAR or OAR; Table [S1](#jah34917-sup-0001){ref-type="supplementary-material"}) were included. To exclude primary hybrid procedures and secondary conversions (EVAR ‐\> OAR), cases with codes for both OAR and EVAR were excluded, as the exact strategy cannot be identified using administrative data. For detailed *ICD‐10* and operationen‐ und prozedurenschlüssel codes, see Table [S1](#jah34917-sup-0001){ref-type="supplementary-material"}; a flowchart of case selection is presented in Figure [1](#jah34917-fig-0001){ref-type="fig"}.

![**Case flowchart.**\
EVAR indicates endovascular aortic repair; OAR, open aortic repair.](JAH3-9-e014534-g001){#jah34917-fig-0001}

Hospital Volume {#jah34917-sec-0013}
---------------

Annual hospital caseload was considered as a surrogate indicator of the theoretical (hidden) construct of "center experience to treat AAA." For each year, the individual hospital volume of AAA repairs (*ICD‐10‐GM* I71.3 for ruptured AAA and I71.4 for iAAA) was calculated. Hospitals were identified by institutional code and site code, which were harmonized over the years by the German Federals Statistical Office. Hospital volume was statistically modeled as a continuous variable.

Patient Characteristics and Treatment {#jah34917-sec-0014}
-------------------------------------

In accordance with a recent study on volume and outcome after AAA repair in the same population,[11](#jah34917-bib-0011){ref-type="ref"} baseline patient (sex, age, and type of admission) and treatment characteristics (type of surgery \[ie, OAR or EVAR\] and length of hospital stay) are described. Comorbidities were identified by use of specific codes for primary or secondary diagnoses (Table [S1](#jah34917-sup-0001){ref-type="supplementary-material"}).[21](#jah34917-bib-0021){ref-type="ref"} The following comorbidities were included: chronic ischemic heart disease, peripheral arterial disease, diabetes mellitus, renal disease, chronic pulmonary disease, and malignant disease. The modified Elixhauser score was calculated as a measure of comorbidity burden and for multivariable adjustment.[22](#jah34917-bib-0022){ref-type="ref"} Age groups (\<65, 65--69, 70--74, 75--79, and \>79 years) were identical to earlier publications in which they were arbitrarily set,[12](#jah34917-bib-0012){ref-type="ref"}, [23](#jah34917-bib-0023){ref-type="ref"} to achieve comparability.

Outcomes {#jah34917-sec-0015}
--------

The primary outcome was in‐hospital mortality after iAAA repair. Any death during hospital stay has to be reported by law. Therefore, data can be regarded as accurate.[11](#jah34917-bib-0011){ref-type="ref"}

Statistical Analysis {#jah34917-sec-0016}
--------------------

Patient characteristics in men and women were compared using the Bonferroni‐corrected *t* test. The Cochran‐Armitage test for trend was used to analyze trends in mortality of the different age groups.

A multilevel logistic regression model allowing for clustering effects of cases treated in the same hospital was fit to the data. Year of treatment was entered as random effect into the model. Besides the variables of interest (age, sex, and volume), Elixhauser comorbidity score and type of treatment (EVAR or OAR) were used as predictor variables. Using a series of Wald tests and interpreting plots of the crude in‐hospital mortality stratified by sex and age, the volume effect was modeled as second‐degree polynomial. Moreover, the fitted model should be able to adjust a volume‐outcome effect with respect to age and sex; thus, pairwise interactions among the variables of interest were included. Finally, this resulted in 13 parameters to be estimated from data with the underlying mathematical formula:$$\begin{array}{cl}
 & {\text{mortality} \sim \text{sex} + \text{age} + \text{volume} + \text{volume}^{2} + \text{sex} \times \text{age}} \\
 & {+ \text{sex} \times \text{volume} + \text{sex} \times \text{volume}^{2} + \text{age}} \\
 & {\times \text{volume} + \text{age} \times \text{volume}^{2} + \text{Elixhauser\ Score} +} \\
 & {1_{{procedure} = {OAR}}{|\text{year}}} \\
\end{array}$$

CIs (Figures [2](#jah34917-fig-0002){ref-type="fig"}, [3](#jah34917-fig-0003){ref-type="fig"} through [4](#jah34917-fig-0004){ref-type="fig"}) were calculated using the empirical covariance matrix and a 95% threshold. In Figure [4](#jah34917-fig-0004){ref-type="fig"}, each line behaves like the first derivative of the corresponding line of Figure [3](#jah34917-fig-0003){ref-type="fig"}. CIs are displayed in the figures for the above‐mentioned age groups, represented by the median age of the group. To create Figures [5](#jah34917-fig-0005){ref-type="fig"} and [6](#jah34917-fig-0006){ref-type="fig"}, the youngest and oldest age group needed to be limited. As the German Federal Statistical Office does not provide minimum and maximum values, the 2.5% and 97.5% group‐specific quantiles were used (50 and 90 years, respectively).

![**Association between in‐hospital mortality (primary outcome) and sex, age, comorbidity, and type of treatment: Forest plot of the underlying model. Sex was evaluated at median volume (14 cases) and median male age (72 years); age was evaluated at median volume (14 cases).**\
To account for clustering of patients within hospitals, and to account for effect of calendar year, the year of treatment and hospital site code were entered as random effects.](JAH3-9-e014534-g002){#jah34917-fig-0002}

![Odds ratios and 95% CIs of the volume‐outcome relationship by sex (women \[**left**\] and men \[**right**\]) and age (indicated by color). The median annual volume (14 cases; indicated by vertical line) was set as reference. Odds ratios were compared with the median annual hospital volume (14 cases) and corresponding 95% CI evaluated at the median age within each age group.](JAH3-9-e014534-g003){#jah34917-fig-0003}

![Odds ratio of volume compared with an increased volume (5 additional cases a year) with 95% CIs by sex (women \[**left**\] and men \[**right**\]) and age (indicated by color) for all cases (open aortic repair and endovascular aortic repair \[EVAR\]). Each line behaves like the first derivative of the corresponding line of Figure [3](#jah34917-fig-0003){ref-type="fig"}. At each volume point, the regression coefficients were treated as normally distributed random variables. Then, all variables except the volume were set constant and the linear predictor of the 2 time points was calculated and subtracted. Then, the corresponding estimator of the SE was calculated. Finally, the linear predictor difference with 95% CI was retransformed to the odds ratio scale.](JAH3-9-e014534-g004){#jah34917-fig-0004}

![Predicted in‐hospital mortality depending on annual hospital volume by sex (women \[**left**\] and men \[**right**\]) and age (indicated by color) for endovascular aortic repair (**A**) and open aortic repair (OAR) (**B**), amended by highlighted extrema (black dots).](JAH3-9-e014534-g005){#jah34917-fig-0005}

![Predicted in‐hospital mortality depending on annual hospital volume by sex (women \[**left**\] and men \[**right**\]) and age (indicated by color) for all cases (open aortic repair and endovascular aortic repair \[EVAR\]), amended by highlighted extrema (black dots). Averaged on Figure [5](#jah34917-fig-0005){ref-type="fig"}A and [5](#jah34917-fig-0005){ref-type="fig"}B by EVAR proportion within each stratum. AAA indicates abdominal aortic aneurysm.](JAH3-9-e014534-g006){#jah34917-fig-0006}

For controlled remote data processing and statistical analysis, SAS software (version 9.2; Microsoft Windows; 2015 SAS Institute Inc, Cary, NC) was used. Findings have been visualized by R (version 3‐5‐1)[24](#jah34917-bib-0024){ref-type="ref"} and the *ggplot2*‐package.[25](#jah34917-bib-0025){ref-type="ref"}

Results {#jah34917-sec-0017}
=======

Study Cohort and Mortality {#jah34917-sec-0018}
--------------------------

The cohort consisted of 94 966 cases with iAAA receiving treatment in a median of 501 hospitals per annum (total \>700 hospitals). Of the total cases, 11 363 (12%) were women. Median age of female patients was 74 years (lower‐upper quartile, quartile 25%--75%, 69--80 years), whereas the median age of male patients was 72 years (quartile 25%--75%, 66--77 years). Overall, the patients had a high comorbidity burden, indicated by a median Elixhauser score of 5 (males, 5 \[quartile 25%--75%, 0--9\]; females, 5 \[quartile 25%--75%, 1--10\]). On comparing male and female patients, differences were found on the frequency of chronic ischemic heart disease (men, 36%; women, 26%; *P*\<0.001) and peripheral arterial disease (men, 30%; women, 36%; *P*\<0.001). Female patients received endovascular therapy less frequently (men, 57%; women, 51%; *P*\<0.001) and hospitalization was longer (median length of hospital stay in men, 11 days \[quartile 25%--75%, 8--16 days\]; median length of hospital stay in women, 13 days \[quartile 25%--75%, 9--18 days\]; *P*\<0.001). The rate of EVAR procedures is significantly associated with age in both female (*P*\<0.001, Cochran‐Armitage test for trend) and male patients (*P*\<0.001). Patient characteristics and treatment details are given in Tables [1](#jah34917-tbl-0001){ref-type="table"} and [2](#jah34917-tbl-0002){ref-type="table"}.

###### 

Characteristics of All Cases (N=94 966) Receiving Treatment of iAAAs in This Study

  Characteristic                                               Men           Women         *P* Value
  ------------------------------------------------------------ ------------- ------------- -----------
  No. of cases                                                 83 603        11 363        ···
  Age, median (quartile~0.25~--quartile~0.75~), y              72 (66--77)   74 (69--80)   \<0.01
  Elixhauser score, median (quartile~0.25~--quartile~0.75~)    5 (0--9)      5 (1--10)     \<0.01
  Comorbidities, n (%)                                                                     
  Chronic ischemic heart disease                               30 100 (36)   2980 (26)     \<0.01
  Peripheral arterial disease                                  25 173 (30)   4056 (36)     \<0.01
  Chronic pulmonary disease                                    15 460 (19)   2204 (19)     0.21
  Diabetes mellitus                                            14 512 (17)   1711 (15)     \<0.01
  Renal disease                                                16 750 (20)   2316 (20)     1.00
  Any malignancy                                               2941 (3.5)    253 (2.2)     \<0.01
  Endovascular therapy, n (%)                                  47 727 (57)   5749 (51)     \<0.01
  Length of stay, median (quartile~0.25~--quartile~0.75~), d   11 (8--16)    13 (9--18)    \<0.01

*P* value calculated with Bonferroni‐corrected *t* test for continuous variables and Bonferroni‐corrected χ^2^ test for nominal variables. iAAA indicates intact abdominal aortic aneurysm.

John Wiley & Sons, Ltd

###### 

Characteristics of All Cases (N=94 966) Receiving Treatment of iAAAs in This Study, by Age Group

  Characteristic                                               Age Group, y                                            
  ------------------------------------------------------------ -------------- ------------ ------------- ------------- ------------
  No. of cases                                                                                                         
  Men                                                          16 889         15 734       20 901        17 173        12 906
  Women                                                        1486           1674         2625          2645          2933
  Elixhauser score, median (quartile~0.25~--quartile~0.75~)                                                            
  Men                                                          2 (0--7)       3 (0--8)     5 (0--9)      5 (0--10)     5 (2--12)
  Women                                                        4 (0--7)       5 (0--9)     5 (0--10)     5 (1--10)     6 (2--12)
  Comorbidities, n (%)                                                                                                 
  Chronic ischemic heart disease                                                                                       
  Men                                                          5030 (30)      5539 (35)    7730 (37)     6746 (39)     5055 (39)
  Women                                                        303 (20)       419 (25)     676 (26)      760 (29)      822 (28)
  Peripheral arterial disease                                                                                          
  Men                                                          5219 (31)      4822 (31)    6309 (30)     5206 (30)     3617 (28)
  Women                                                        630 (42)       702 (42)     958 (37)      917 (35)      849 (29)
  Chronic pulmonary disease                                                                                            
  Men                                                          2607 (15)      2919 (19)    4092 (20)     3431 (20)     2411 (19)
  Women                                                        298 (20)       401 (24)     565 (22)      513 (19)      427 (15)
  Diabetes mellitus                                                                                                    
  Men                                                          2698 (16)      2871 (18)    3872 (19)     3108 (18)     1963 (15)
  Women                                                        177 (12)       240 (14)     437 (17)      438 (17)      419 (14)
  Renal disease                                                                                                        
  Men                                                          1868 (11)      2477 (16)    4165 (20)     4354 (25)     3886 (30)
  Women                                                        160 (11)       284 (17)     486 (19)      612 (23)      774 (26)
  Any malignancy                                                                                                       
  Men                                                          372 (2.2)      509 (3.2)    804 (3.8)     737 (4.3)     519 (4.0)
  Women                                                        31 (2.1)       42 (2.5)     55 (2.1)      55 (2.1)      70 (2.4)
  Endovascular therapy, n (%)                                                                                          
  Men                                                          7811 (46)      7785 (49)    11 933 (57)   10 678 (62)   9520 (74)
  Women                                                        533 (36)       621 (37)     1222 (47)     1454 (55)     1919 (65)
  Length of stay, median (quartile~0.25~--quartile~0.75~), d                                                           
  Men                                                          11 (8--14)     11 (8--15)   11 (8--16)    11 (8--17)    11 (8--17)
  Women                                                        12 (9--17)     13 (9--18)   13 (9--18)    13 (9--19)    14 (9--20)

iAAA indicates intact abdominal aortic aneurysm.

John Wiley & Sons, Ltd

Overall mortality was 3.2%: However, mortality was \>1.5 times higher in women (4.9%) than in men (3.0%; *P*\<0.001). In cases treated with OAR, mortality was 5.2% (men, 5.0%; women, 7.0%; *P*\<0.001), compared with 1.6% after EVAR (men, 1.5%; women, 2.9%; *P*\<0.001). Mortality increased with patient age for both EVAR and OAR (*P*\<0.001; Table [3](#jah34917-tbl-0003){ref-type="table"}).

###### 

In‐Hospital Mortality After Open and Endovascular iAAA Repair

  Variable                       All Cases    \<65 y      65--69 y    70--74 y    75--79 y    \>79 y       *P* Value
  ------------------------------ ------------ ----------- ----------- ----------- ----------- ------------ -----------
  Overall (*P*\<0.01)                                                                                      
  No. of cases                                                                                             
  Men                            83 603       16 889      15 734      20 901      17 173      12 906       ···
  Women                          11 363       1486        1674        2625        2645        2933         ···
  Death until discharge, n (%)                                                                             
  Men                            2482 (3.0)   229 (1.4)   314 (2.0)   551 (2.6)   732 (4.3)   656 (5.1)    \<0.01
  Women                          557 (4.9)    30 (2.0)    65 (3.9)    119 (4.5)   143 (5.4)   200 (6.8)    \<0.01
  OAR (*P*\<0.01)                                                                                          
  No. of cases                                                                                             
  Men                            35 876       9078        7949        8968        6495        3386         ···
  Women                          5614         953         1053        1403        1191        1014         ···
  Death until discharge, n (%)                                                                             
  Men                            1776 (5.0)   195 (2.1)   251 (3.2)   415 (4.6)   505 (7.8)   410 (12.1)   \<0.01
  Women                          393 (7.0)    21 (2.2)    52 (4.9)    98 (7.0)    94 (7.9)    128 (12.6)   \<0.01
  EVAR (*P*\<0.01)                                                                                         
  No. of cases                                                                                             
  Men                            47 727       7811        7785        11 933      10 678      9520         ···
  Women                          5749         533         621         1222        1454        1919         ···
  Death until discharge, n (%)                                                                             
  Men                            706 (1.5)    34 (0.4)    63 (0.8)    136 (1.1)   227 (2.1)   246 (2.6)    \<0.01
  Women                          164 (2.9)    9 (1.7)     13 (2.1)    21 (1.7)    49 (3.4)    72 (3.8)     \<0.01

*P* values of the Bonferroni‐corrected χ^2^ test comparing men vs women are given next to treatment modality. *P* value of Cochran‐Armitage test for trend is given in the right column. EVAR indicates endovascular aortic repair; iAAA, intact abdominal aortic aneurysm; and OAR, open aortic repair.

John Wiley & Sons, Ltd

The median caseload of hospitals and their distribution within volume quartiles are presented in Tables [S2](#jah34917-sup-0001){ref-type="supplementary-material"} and [S3](#jah34917-sup-0001){ref-type="supplementary-material"}.

Volume‐Outcome Relationship and Interaction With Sex and Age {#jah34917-sec-0019}
------------------------------------------------------------

The results of the fitted multilevel logistic regression model are illustrated in Figures [2](#jah34917-fig-0002){ref-type="fig"}, [3](#jah34917-fig-0003){ref-type="fig"}, [4](#jah34917-fig-0004){ref-type="fig"}, [5](#jah34917-fig-0005){ref-type="fig"} through [6](#jah34917-fig-0006){ref-type="fig"}.

Figure [2](#jah34917-fig-0002){ref-type="fig"} shows the odds ratios (ORs) of the statistical model underlying the further analysis. As sex interacted with both age and volume, the ORs are observed by inserting the median male age (72 years) and/or the median volume (14 cases), which resulted in an OR of 0.87 \[95% CI 0.47--1.62\]. Increasing age is significantly associated with mortality in both male (OR, 1.81 \[1.79--1.82\] per 10‐year increase; *P*\<0.01) and female patients (OR, 1.67 \[1.66--1.68\] per 10‐year increase; *P*\<0.01). Increased Elixhauser comorbidity score (OR, 1.82 \[1.77--1.87\] per 5‐point increase; *P*\<0.01) and an OAR procedure (OR, 3.68 \[3.33--4.96\]; *P*\<0.01) are significant risk factors for in‐hospital mortality.

The accuracy of the statistical model (predicted mortality) was cross‐checked with actual outcomes (observed mortality). The results are presented in Tables [S4](#jah34917-sup-0001){ref-type="supplementary-material"} and [S5](#jah34917-sup-0001){ref-type="supplementary-material"}.

Figure [3](#jah34917-fig-0003){ref-type="fig"} shows the ORs and 95% CIs for the volume‐outcome relationship (reference, 14 cases/year) differentiated by age group and sex. Overall, the predicted effect of hospital volume is only statistically evident for male patients. This is indicated by the maximum benefit of male patients (OR, 0.60--0.75; *P*=0.02), which is more pronounced than the maximum benefit of women (OR, 0.85--1.00; *P*=0.57). Furthermore, the volume‐outcome effect is more distinct in younger patients, as indicated by staggered OR curves in both sexes, starting with the youngest subgroups at the bottom (lowest OR; Figure [3](#jah34917-fig-0003){ref-type="fig"}). This means that the strongest volume‐outcome association was found in the younger male subpopulation, as indicated by the slopes in Figure [4](#jah34917-fig-0004){ref-type="fig"}. These figures also show an inverse volume‐outcome relationship in the younger female subpopulation, whereas an opposite association was found for the women aged \>79 years.

The volume intervals related to beneficial (meaning that higher volumes are related to lower mortality) or possible adverse effects on outcome are displayed in Table [4](#jah34917-tbl-0004){ref-type="table"}. Positive volume effects were found for all age groups, but the range of volume differs in each group. In female patients aged \<70 years, a positive effect was found all over the viewed volume range of 1 to 120 cases per year, and if the caseload exceeded 40, 68, or 94 in the 70 to 74, 75 to 79, and ≥80‐year age groups, respectively. For male patients, a positive effect of increasing annual hospital volume was shown for all age groups up to an annual volume between 89 and 97 cases (depending on age group). Conversely, if the annual volume exceeded a certain value (98--103, depending on age group), a negative effect was seen. In Figure [4](#jah34917-fig-0004){ref-type="fig"}, each line behaves like the first derivative of the corresponding line of Figure [3](#jah34917-fig-0003){ref-type="fig"} (ie, the bigger the magnitude in Figure [3](#jah34917-fig-0003){ref-type="fig"}, the steeper the graph in Figure [4](#jah34917-fig-0004){ref-type="fig"}; negative/positive regions in Figure [4](#jah34917-fig-0004){ref-type="fig"} are associated with decreasing/increasing regions in Figure [3](#jah34917-fig-0003){ref-type="fig"}).

###### 

Volume Range (1--120) Allocated Into Areas of Effect Quality (Beneficial, No, and Adverse) for Each Sex and Age Group Individually

                          Women    Men                                 
  -------------- -------- -------- ------- ------- --------- --------- -------
  Age group, y   50--64   1--120   ···     ···     1--97     98--103   \>103
  65--69         1--120   ···      ···     1--96   96--101   \>102     
  70--74         \>40     1--40    ···     1--94   95--100   \>100     
  75--79         \>68     7--68    1--6    1--93   94--98    \>98      
  80--90         \>94     44--94   1--43   1--89   90--97    \>97      

Cutting points were calculated on the basis of Figure [3](#jah34917-fig-0003){ref-type="fig"}, particularly the cut points of the 95% CIs and the OR=1.0 line. OR indicates odds ratio.

John Wiley & Sons, Ltd

Predicted mortality specific for EVAR and OAR is plotted in Figure [5](#jah34917-fig-0005){ref-type="fig"}. Predicted overall in‐hospital mortality is plotted in Figure [6](#jah34917-fig-0006){ref-type="fig"} (weighted for EVAR proportion).

Discussion {#jah34917-sec-0020}
==========

Overall, an inverse relationship between the annual hospital volume of iAAA repairs and in‐hospital mortality was confirmed. No significant volume‐outcome effect was evident among female patients. Interestingly, the effect was more pronounced in young male patients, who are usually deemed to have a lower perioperative risk. Female sex and age were identified as independent risk factors for in‐hospital mortality. Sex and age were modifiers of the volume‐outcome relationship. The age effect was not confounded by sex. Furthermore, increasing age, comorbidity, and OAR were associated with a higher risk for in‐hospital mortality.

Interaction Between Volume, Sex, Age, and Mortality {#jah34917-sec-0021}
---------------------------------------------------

To the best of the authors' knowledge, this is the first study to examine effect modification of the volume‐outcome relationship by patient sex and age. The volume‐outcome effect is widely known[2](#jah34917-bib-0002){ref-type="ref"}, [3](#jah34917-bib-0003){ref-type="ref"}, [4](#jah34917-bib-0004){ref-type="ref"}, [5](#jah34917-bib-0005){ref-type="ref"}, [6](#jah34917-bib-0006){ref-type="ref"}, [7](#jah34917-bib-0007){ref-type="ref"} and has been demonstrated in the same nationwide German setting before.[11](#jah34917-bib-0011){ref-type="ref"} In a further analysis of risk factors for AAA treatment in Germany, female sex and age were associated with in‐hospital mortality.[12](#jah34917-bib-0012){ref-type="ref"} Taking these results together, the hypothesis of the present study was that the volume‐outcome effect would be more pronounced in higher‐risk patients (older age and women). This was supported by analogous findings in percutaneous coronary artery interventions, where a volume‐outcome effect could only be shown for high‐risk procedures.[10](#jah34917-bib-0010){ref-type="ref"} Looking at the results of the present study, this hypothesis cannot be confirmed for iAAA treatment. In general, the volume‐outcome effect was not evident for women. Looking at Figure [1](#jah34917-fig-0001){ref-type="fig"} in detail, the model predicts no advantage of treating older women in hospitals with a higher annual caseload but rather a nearly linear decrease of the OR among younger women. In contrast, for male patients, a positive effect of increasing annual hospital volume was shown for all age groups up to an annual volume of ≈100 cases. In hospitals treating \>100 cases per year, mortality increased again. This increase of mortality in high‐volume hospitals is known from other studies, and several possible reasons have been discussed. The most likely causes are selection bias and confounding by unobserved/undocumented factors (eg, cases with complex aortic pathological conditions, teaching status of hospitals, and individual surgeon volume in high‐volume hospitals).[11](#jah34917-bib-0011){ref-type="ref"}, [26](#jah34917-bib-0026){ref-type="ref"} Although it was not the aim of the present study to define an overall case threshold for AAA repair, it seems that the recent guideline recommendations of the Society of Vascular Surgery (10 OAR/10 EVAR cases per year)[8](#jah34917-bib-0008){ref-type="ref"} and European Society of Vascular and Endovascular Surgery (30 AAA cases per year)[9](#jah34917-bib-0009){ref-type="ref"} may be set too low, and almost all patients might potentially benefit from higher thresholds.

Possible reasons for the worse in‐hospital outcomes in women compared with men have been discussed in detail recently.[12](#jah34917-bib-0012){ref-type="ref"}, [27](#jah34917-bib-0027){ref-type="ref"}, [28](#jah34917-bib-0028){ref-type="ref"} Apart from more complicated AAA morphological characteristics (calcification, shorter neck, and smaller access vessels), the greater age and possible underdiagnosed cardiovascular and pulmonary disease in women are reasonable explanations. Thus, women may benefit from more extensive preoperative workup (eg, noninvasive cardiac evaluation and lung function tests).

A recent analysis showed that young male patients face the lowest risk in AAA repair.[12](#jah34917-bib-0012){ref-type="ref"} In the present analysis, this patient group showed the most pronounced relative effect of annual hospital volume on postoperative mortality. A conclusion on why particularly patients who are deemed to be at a lower risk are more affected by annual hospital volume and why no benefit can be shown for female patients cannot be drawn from the present analysis. A possible explanation might be "failure to rescue," which describes the inability of a hospital or team to save a patient′s life if complications occur. In other settings, such as esophageal and pancreatic surgery,[29](#jah34917-bib-0029){ref-type="ref"}, [30](#jah34917-bib-0030){ref-type="ref"} but also for cardiac and AAA surgery,[31](#jah34917-bib-0031){ref-type="ref"} failure to rescue is used to explain the volume‐outcome effect on mortality. Complication rates in these studies were not dependent on volume. Mortality and consequently failure to rescue rates were lower in high‐volume hospitals. Complication rates and their dependency on volume after AAA surgery in Germany have been analyzed in the same setting as the present study.[11](#jah34917-bib-0011){ref-type="ref"} Although an inverse association of hospital volume with complication rates was seen for bleeding complications (indicated by amount of blood transfusion) and peripheral arterial embolism, other severe complication rates (acute myocardial infarction, acute stroke, and mesenteric ischemia) were not associated with annual AAA volume.[11](#jah34917-bib-0011){ref-type="ref"} Transferring these findings to the present study, this might imply that the patients deemed to be at low risk for surgery might benefit the most from the ability to rescue in high‐volume hospitals. Further studies are needed to confirm this possible explanation.

Strengths and Limitations {#jah34917-sec-0022}
-------------------------

The main strength of this secondary data analysis of German routine data is its nationwide coverage and accuracy on the "hard" outcome of in‐hospital death. Nevertheless, the findings have to be interpreted in the context of several limitations that have also been discussed in detail in former publications.[14](#jah34917-bib-0014){ref-type="ref"}, [32](#jah34917-bib-0032){ref-type="ref"}

This observational study can only prove statistical associations, rather than causal relationships. Furthermore, the administrative nature of the data set does not allow adjustment of the statistical model for important factors, such as anatomical factors (especially aneurysm extent and diameter), urgency of treatment, and patient frailty. Adjusting the data for Elixhauser score, which was developed to provide a predictive score for in‐hospital mortality in administrative data sets, was regarded as the best tool to adjust analyses for comorbidity burden.[22](#jah34917-bib-0022){ref-type="ref"}

The record of a case ends at discharge; therefore, only in‐hospital outcomes can be reported. Furthermore, median length of hospital stay was 2 days longer in women compared with men (13 versus 11 days). However, for the main research question (sex differences in the volume‐outcome effect after iAAA surgery), the risk of bias attributable to different length of hospital stay was considered low.

Potential miscoding could have biased case selection and grouping. Although upcoding of secondary diagnoses is considered unlikely (because of frequent monitoring of the medical service by health insurance companies), secondary diagnoses might not be coded if they are not relevant for reimbursement. Nonetheless, it is important to mention that data collection and validation for this data set are regulated by German Social Law, and German hospitals are statutorily committed to submit their data. Last, further follow‐up after hospital discharge is not possible using this data set; therefore, a possible effect of hospital volume on long‐term survival after AAA repair cannot be evaluated.

Conclusions {#jah34917-sec-0023}
===========

Operations on iAAA remain high‐risk procedures, even in the endovascular era. Overall, an inverse relationship between annual hospital volume of iAAA repairs and in‐hospital mortality was confirmed. Interestingly, the effect was most pronounced in young male patients who are usually deemed to have a lower perioperative risk. No significant volume‐outcome effect was evident when all female patients were taken together. In younger female patients, a positive, but barely relevant, effect of hospital volume on mortality could still be shown. Sex and age were modifiers of the volume‐outcome relationship. The age effect was not confounded by sex. As the vast majority of patients are men, these findings do not contradict demands for centralization of AAA, irrespective of the type of AAA procedure. However, for female patients, centralization may not lead to a relevant reduction of their perioperative risk. Further studies are needed to identify the underlying causal factors and improve AAA treatment for women.
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